ERBB2 and cancer: The model demonstrated robust performance across multicenter datasets, achieving AUC values of 0.73 and 0.71 in external test sets for distinguishing HER2‐zero from HER2‐low/positive cancers, and 0.80 and 0.79 for distinguishing HER2‐low from HER2‐positive cancers.